Clinical and basic researches on HIV/AIDS.
- Author:
Yun-zhen CAO
1
Author Information
1. AIDS Research Center, CAMS and PUMC, Beijing 100730, China. dryunzhencao@yahoo.com
- Publication Type:Journal Article
- MeSH:
Antiretroviral Therapy, Highly Active;
CD4-Positive T-Lymphocytes;
immunology;
HIV Infections;
drug therapy;
immunology;
prevention & control;
Humans
- From:
Acta Academiae Medicinae Sinicae
2006;28(5):609-612
- CountryChina
- Language:Chinese
-
Abstract:
Worldwide, about 85% of human immunodeficiency virus (HIV) infections were acquired through sexual transmission. Control strategies have been focused on behavioral change through educational efforts and condom promotion, which had achieved certain success in several countries. The past decade witnessed the extraordinary advances in highly active antiretroviral therapy (HAART) and its effectiveness. HAART fundamentally alters the course of HIV-1 infection by decreasing the plasma viral load to the undetectable level and increasing the number of CD4 + T cells. However, problems including drug resistance and adverse events also exist in HAART. In the near future, the major challenges may include: determining the role and efficacy of new drugs and new therapies; addressing the coinfection of HIV/liver diseases/tuberculosis; improving the savage management; addressing the issues faced by the resource-limited countries; and achieving further success in HIV/AIDS prevention and treatment.
